Bezatol SR


Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 21.3%
Hyperlipidaemia 18.9%
Atrial Fibrillation 9.8%
Product Used For Unknown Indication 6.6%
Benign Prostatic Hyperplasia 4.9%
Hyperuricaemia 4.9%
Prophylaxis Of Nausea And Vomiting 4.1%
Cardiac Failure Congestive 3.3%
Onychomycosis 3.3%
Psoriasis 3.3%
Cardiac Failure 2.5%
Cerebral Infarction 2.5%
Dyslipidaemia 2.5%
Gastritis 2.5%
Diabetes Mellitus 1.6%
Drug Use For Unknown Indication 1.6%
Hypercholesterolaemia 1.6%
Osteoporosis 1.6%
Prostate Cancer 1.6%
Type 2 Diabetes Mellitus 1.6%
Rhabdomyolysis 31.4%
Dermatitis Exfoliative 8.6%
Hepatitis Acute 8.6%
Blood Creatine Phosphokinase Increased 5.7%
Interstitial Lung Disease 5.7%
Unresponsive To Stimuli 5.7%
Accommodation Disorder 2.9%
Blood Creatinine Increased 2.9%
Coagulopathy 2.9%
Gastric Cancer 2.9%
Low Density Lipoprotein Increased 2.9%
Melaena 2.9%
Myopathy 2.9%
Neoplasm Malignant 2.9%
Oedema 2.9%
Pigmentation Disorder 2.9%
Renal Failure Chronic 2.9%
Renal Impairment 2.9%
Concomitant
Hypertension 11.1%
Hyperlipidaemia 10.4%
Prophylaxis 9.2%
Diabetes Mellitus 9.1%
Drug Use For Unknown Indication 8.7%
Hiv Infection 5.7%
Insomnia 5.0%
Rheumatoid Arthritis 5.0%
Depression 4.8%
Product Used For Unknown Indication 4.5%
Asthma 3.1%
Multiple Myeloma 3.1%
Chronic Hepatitis C 3.1%
Hepatitis C 3.1%
Gastritis 3.0%
Hyperuricaemia 2.6%
Type 2 Diabetes Mellitus 2.5%
Infection Prophylaxis 2.2%
Juvenile Arthritis 2.2%
Bipolar I Disorder 1.8%
Renal Impairment 10.4%
Pyrexia 9.6%
Interstitial Lung Disease 8.7%
White Blood Cell Count Decreased 7.8%
Rash 7.0%
Malaise 6.1%
Histiocytosis Haematophagic 5.2%
Pneumonia 4.3%
Rhabdomyolysis 4.3%
Sepsis 4.3%
Sudden Death 4.3%
Vitreous Haemorrhage 4.3%
Cerebral Haemorrhage 3.5%
Idiopathic Thrombocytopenic Purpura 3.5%
Lymphangiosis Carcinomatosa 3.5%
Asthma 2.6%
Autoimmune Hepatitis 2.6%
Drug Eruption 2.6%
Hepatic Function Abnormal 2.6%
Hyperuricaemia 2.6%

Drug Data